These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

521 related articles for article (PubMed ID: 28750432)

  • 1. Hyperthyroidism in Patients with Graves' Ophthalmopathy, and Thyroidal, Skeletal and Eye Muscle Specific Type 2 Deiodinase Enzyme Activities.
    Molnár I; Szentmiklósi JA; Somogyiné-Vári É
    Exp Clin Endocrinol Diabetes; 2017 Sep; 125(8):514-521. PubMed ID: 28750432
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of antithyroid drugs on the occurrence of antibodies against type 2 deiodinase (DIO2), which are involved in hyperthyroid Graves' disease influencing the therapeutic efficacy.
    Molnár I; Szentmiklósi JA; Gesztelyi R; Somogyiné-Vári É
    Clin Exp Med; 2019 May; 19(2):245-254. PubMed ID: 30610492
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Immunohistochemical studies using immunized Guinea pig sera with features of anti-human thyroid, eye and skeletal antibody and Graves' sera.
    Molnár I; Szombathy Z; Kovács I; Szentmiklósi AJ
    J Clin Immunol; 2007 Mar; 27(2):172-80. PubMed ID: 17243008
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Thyroid-stimulating antibody is related to Graves' ophthalmopathy, but thyrotropin-binding inhibitor immunoglobulin is related to hyperthyroidism in patients with Graves' disease.
    Noh JY; Hamada N; Inoue Y; Abe Y; Ito K; Ito K
    Thyroid; 2000 Sep; 10(9):809-13. PubMed ID: 11041459
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Enhanced thyroid iodine metabolism in patients with triiodothyronine-predominant Graves' disease.
    Takamatsu J; Hosoya T; Naito N; Yoshimura H; Kohno Y; Tarutani O; Kuma K; Sakane S; Takeda K; Mozai T
    J Clin Endocrinol Metab; 1988 Jan; 66(1):147-52. PubMed ID: 3335601
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cloning and characterization of the novel thyroid and eye muscle shared protein G2s: autoantibodies against G2s are closely associated with ophthalmopathy in patients with Graves' hyperthyroidism.
    Gunji K; De Bellis A; Li AW; Yamada M; Kubota S; Ackrell B; Wengrowicz S; Bellastella A; Bizzarro A; Sinisi A; Wall JR
    J Clin Endocrinol Metab; 2000 Apr; 85(4):1641-7. PubMed ID: 10770210
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Corticosteroids in Moderate-To-Severe Graves' Ophthalmopathy: Oral or Intravenous Therapy?
    Penta L; Muzi G; Cofini M; Leonardi A; Lanciotti L; Esposito S
    Int J Environ Res Public Health; 2019 Jan; 16(1):. PubMed ID: 30626069
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Serum immunoglobulin G4 levels and Graves' disease phenotype.
    Martin CS; Sirbu AE; Betivoiu MA; Florea S; Barbu CG; Fica SV
    Endocrine; 2017 Feb; 55(2):478-484. PubMed ID: 27819113
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Studies of thyroid function and immune parameters in patients with hyperthyroid Graves' disease in remission.
    Murakami M; Koizumi Y; Aizawa T; Yamada T; Takahashi Y; Watanabe T; Kamoi K
    J Clin Endocrinol Metab; 1988 Jan; 66(1):103-8. PubMed ID: 3121661
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Association of thyrotrophin receptor antibodies with the clinical features of Graves' ophthalmopathy.
    Gerding MN; van der Meer JW; Broenink M; Bakker O; Wiersinga WM; Prummel MF
    Clin Endocrinol (Oxf); 2000 Mar; 52(3):267-71. PubMed ID: 10718823
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparative study on IgG and IgA antibodies against human thyroid and eye-muscle antigens in Graves' ophthalmopathy.
    Molnár I; Balázs C
    Acta Med Hung; 1991; 48(1-2):13-21. PubMed ID: 1813853
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Type 1 and type 2 iodothyronine deiodinases in the thyroid gland of patients with 3,5,3'-triiodothyronine-predominant Graves' disease.
    Ito M; Toyoda N; Nomura E; Takamura Y; Amino N; Iwasaka T; Takamatsu J; Miyauchi A; Nishikawa M
    Eur J Endocrinol; 2011 Jan; 164(1):95-100. PubMed ID: 20937676
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Thyroid peroxidase activity-inhibiting immunoglobulins in patients with autoimmune thyroid disease.
    Okamoto Y; Hamada N; Saito H; Ohno M; Noh J; Ito K; Morii H
    J Clin Endocrinol Metab; 1989 Apr; 68(4):730-4. PubMed ID: 2921308
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Serum antibodies against the flavoprotein subunit of succinate dehydrogenase are sensitive markers of eye muscle autoimmunity in patients with Graves' hyperthyroidism.
    Gunji K; De Bellis A; Kubota S; Swanson J; Wengrowicz S; Cochran B; Ackrell BA; Salvi M; Bellastella A; Bizzarro A; Sinisi AA; Wall JR
    J Clin Endocrinol Metab; 1999 Apr; 84(4):1255-62. PubMed ID: 10199764
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Soluble intercellular adhesion molecule-1 (sICAM-1) in Graves' disease.
    Balázs C; Kiss E
    Acta Microbiol Immunol Hung; 1994; 41(4):451-6. PubMed ID: 7866729
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Serum concentrations of adiponectin and resistin in hyperthyroid Graves' disease patients.
    Sieminska L; Niedziolka D; Pillich A; Kos-Kudla B; Marek B; Nowak M; Borgiel-Marek H
    J Endocrinol Invest; 2008 Sep; 31(9):745-9. PubMed ID: 18997483
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Sight-Threatening Graves' Ophthalmopathy during the Third Trimester of Pregnancy: A Case Report.
    Sakurai K; Inoue T; Niitsuma S; Sato R; Takahashi K; Arihara Z
    Tohoku J Exp Med; 2020 Dec; 252(4):321-327. PubMed ID: 33268601
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Serum antibodies reactive with eye muscle antigens and the TSH receptor in a euthyroid subject who developed ophthalmopathy and Graves' hyperthyroidism.
    Wall J; Barsouk A; Stolarski C; Kiljanski J; Stachura I; Nebes V; Peele K; Volpe R; Kennerdell J
    Thyroid; 1996 Aug; 6(4):353-8. PubMed ID: 8875760
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Temporal relationship between onset of Graves' ophthalmopathy and onset of thyroidal Graves' disease.
    Wiersinga WM; Smit T; van der Gaag R; Koornneef L
    J Endocrinol Invest; 1988 Sep; 11(8):615-9. PubMed ID: 2907524
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of thyrotropin-releasing hormone on serum thyroid hormones: a study in the patients with untreated and treated Graves' disease and subacute thyroiditis.
    Sato A; Yamada T; Aizawa T; Ichikawa K; Komiya I; Takasu N; Takemura Y
    J Clin Endocrinol Metab; 1995 Jul; 80(7):2173-7. PubMed ID: 7608274
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 27.